IGM Biosciences Stock Price - IGMS

0.00 (0.0%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
IGM Biosciences Inc IGMS NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 64.06 0.00 0.00 0.00 64.06 07:00:13
Bid Price Ask Price Spread Spread % News
52.80 66.50 13.70 20.6% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 64.06 USD

IGM Biosciences Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.96B 30.59M 30.08M $ - $ - 7.12 8.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 16.00 1.70%

more financials information »

IGM Biosciences News

Date Time Source News Article
5/28/202007:00GlobeNewswire Inc.IGM Biosciences to Present at the Jefferies 2020 Healthcare..
5/12/202007:00GlobeNewswire Inc.IGM Biosciences to Present at the 2020 RBC Capital Markets..
5/07/202016:32Edgar (US Regulatory)Current Report Filing (8-k)
5/07/202016:03GlobeNewswire Inc.IGM Biosciences Announces First Quarter 2020 Financial..
5/07/202016:02Edgar (US Regulatory)Quarterly Report (10-q)
4/29/202016:05GlobeNewswire Inc.Atreca, BeiGene, and IGM Biosciences Agree to Collaborate on..
4/21/202017:26Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IGMS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week59.9868.0059.0063.95115,7494.086.8%
1 Month54.9868.0051.4559.7283,2619.0816.52%
3 Months52.7570.0027.5552.7490,07611.3121.44%
6 Months23.0074.1319.60544.92129,33141.06178.52%
1 Year18.3174.1316.1038.24127,69945.75249.86%
3 Years18.3174.1316.1038.24127,69945.75249.86%
5 Years18.3174.1316.1038.24127,69945.75249.86%

IGM Biosciences Description

IGM Biosciences Inc is a biotechnology company involved in the development of engineered IgM antibodies for the treatment of cancer patients. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies.
Your Recent History
IGM Biosci..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200602 12:29:13